US Representative

Paul Gosar 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 10)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB372

Introduced
1/17/23  
Refer
1/17/23  
Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB374

Introduced
1/17/23  
Abolish the ATF Act This bill abolishes the Bureau of Alcohol, Tobacco, Firearms and Explosives.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3740

Introduced
5/26/23  
Federal Employee Student Debt Transparency Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3741

Introduced
5/23/23  
Refer
5/26/23  
To amend title X of the Public Health Service Act to prohibit funds under such title from being used for any system through which counseling or referrals are provided to individuals regarding abortion services.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3754

Introduced
5/30/23  
Restoring Vehicle Market Freedom Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3757

Introduced
5/31/23  
Defund the CCP On Campus Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB38

Introduced
1/9/23  
Concealed Carry Reciprocity Act This bill establishes a federal statutory framework to regulate the carry or possession of concealed firearms across state lines. Specifically, an individual who is eligible to carry a concealed firearm in one state may carry or possess a concealed handgun (other than a machine gun or destructive device) in another state that allows its residents to carry concealed firearms. It sets forth requirements for the lawful concealed carry across state lines. The bill preempts most state and local laws related to concealed carry and establishes a private right of action for a person adversely affected by interference with a concealed-carry right established by this bill.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB381

Introduced
1/17/23  
Protecting Individual Sovereignty Through Our Laws Act or the PISTOL Act This bill modifies the definition of rifle for purposes of the National Firearms Act to exclude from such definition a pistol equipped with a rear brace or rear attachment designed to assist the shooter in controlling the pistol. The bill also directs the Department of Justice to amend applicable regulations governing pistols to provide that the presence or absence of rear mounted braces or attachments that can assist a user in controlling the pistol shall not cause a firearm to be considered a pistol.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB382

Introduced
1/17/23  
Refer
1/17/23  
Refer
1/27/23  
Pandemic is Over Act This bill terminates the COVID-19 public health emergency that was declared on January 31, 2020, on the date of the bill's enactment.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB383

Introduced
1/17/23  
Refer
1/17/23  
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB384

Introduced
1/17/23  
Refer
1/17/23  
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB385

Introduced
1/17/23  
No User Fees for Gun Owners Act This bill prohibits a state or local government from imposing any insurance requirement, tax, user fee, or similar charge as a condition of the manufacture importation, acquisition, transfer, or continued ownership of a firearm or ammunition, with the exception of a proportionate sales tax. The bill imposes the same prohibition under the Internal Revenue Code for firearms, pistols, or revolvers, but allows for the assessment of a proportionate sales tax.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3885

Introduced
6/7/23  
Refer
6/7/23  
To amend the Energy Act of 2020 to include copper as a critical mineral, and for other purposes.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3968

Introduced
6/9/23  
End Child Trafficking Now Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB3988

Introduced
6/9/23  
Refer
6/9/23  
Refer
6/12/23  
ARTICLE ONE Act Assuring that Robust, Thorough, and Informed Congressional Leadership is Exercised Over National Emergencies Act